The effect of combination chemotherapy on ovarian function in women treated for hodgkin's disease
β Scribed by E. Whitehead; Dr. S. M. Shalet; G. Blackledge; I. Todd; D. Crowther; C. G. Beardwell
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 548 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Testicular dysfunction with elevated follicle-stimulating hormone (FSH) levels (indicating oligospermia and/or azoospermia) is a major late sequelae after treatment for Hodgkin's disease (HD) with high cumulative doses of procarbazine, cyclophosphamide, or chlorambucil. Etoposide is
## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo